The DOI matches its Crossref record; 425 of the 429 references it cites were found in a registry or an index.
New Developments in Liposomal Drug Delivery
Abstract
ADVERTISEMENT RETURN TO ISSUEPREVReviewNEXTNew Developments in Liposomal Drug DeliveryBhushan S. Pattni†, Vladimir V. Chupin‡, and Vladimir P. Torchilin*†§View Author Information† Department of Pharmaceutical Sciences, Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston, Massachusetts 02115, United States‡ Laboratory for Advanced Studies of Membrane Proteins, Moscow Institute of Physics and Technology, Dolgoprudny 141700, Russia§ Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia*Tel.: (617) 373-3206. E-mail: [email protected]Cite this: Chem. Rev. 2015, 115, 19, 10938–10966Publication Date (Web):May 26, 2015Publication History Received23 January 2015Published online26 May 2015Published inissue 14 October 2015https://pubs.acs.org/doi/10.1021/acs.chemrev.5b00046https://doi.org/10.1021/acs.chemrev.5b00046review-articleACS PublicationsCopyright © 2015 American Chemical SocietyRequest reuse permissionsArticle Views20991Altmetric-Citations1149LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Cancer,Drug delivery,Encapsulation,Lipids,Vesicles Get e-Alerts
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NL forms a protective barrier that protects the molecules from degradation by enzymes in the mouth and stomach, digestive juices, bile acid, and intestinal microorganisms [41,42].”
From Alzheimer's Disease: Treatment Strategies and Their Limitations. (2022) · cites this paper as [42]
In the citing paper
“Since liposomes can improve drug delivery to solid tumors, we explored their potential as an enabling technology for echinomycin in solid tumors26.”
From Liposomal Formulation of HIF-1α Inhibitor Echinomycin Eliminates Established Metastases of Triple-negative Breast Cancer (2020) · cites this paper as [26]
Citations
Cites
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Self-citationDoxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792
Diffusion of univalent ions across the lamellae of swollen phospholipids
Bangham, A. D., Standish, M. M., & Watkins, J. C. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80093-6 · Cited by 4,664
Cancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558
Fang, J. Q., Nakamura, H., & Maeda, H. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.04.009 · Cited by 3,573
Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438
Self-citationSzoka, F. C., & Papahadjopoulos, D. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.9.4194 · Cited by 2,350
Treatment of Age-related Macular Degeneration With Photodynamic Therapy (TAP) Study Group (1999) · Archives of Ophthalmology · doi:10.1001/archopht.117.10.1329 · Cited by 2,192
Hope, M. J., Bally, M. B., Webb, G., & Cullis, P. R. (1985) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(85)90521-8 · Cited by 2,078
Research works printed but not linked: 36
- Vanlerberghe G., 1996, Handbook of Nonmedical Applications of Liposomes, Vol. IV: From Gene Delivery and Diagnosis to Ecology, 4, 77
- Glantz M. J., 1999, Clin. Cancer Res., 5, 3394
- 2000, Med. Lett. Drugs Ther., 42, 81
- Bressler N. M., 2000, Invest. Ophthalmol. Visual Sci., 41, 624
- Schuch G., 2005, Curr. Opin. Invest. Drugs, 6, 1259
- Saif M. W., 2014, JOP, 15, 278
- Tari A. M., 2007, Int. J. Oncol., 31, 1243
- Hoving S., 2005, Anticancer Res., 25, 743
- Tardi P., 2000, Cancer Res., 60, 3389
- Liu Y., 2006, Zhongguo Yixue Kexueyuan Xuebao, 28, 583
- Campbell R. B., 2002, Cancer Res., 62, 6831
- Karn P. R., 2013, Int. J. Nanomed., 8, 365
- Erdoğan S., 2006, FABAD J. Pharm. Sci., 31, 182
- Müller M., 2004, Int. J. Pharm., 274, 139, 10.1016/j.ijpharm.2004.01.015 · DOI
- Tunsirikongkon A., 2014, Int. J. Pharm. Pharm. Sci., 6, 546
- Yuan F., 1995, Cancer Res., 55, 3752
- Matsumura Y., 1986, Cancer Res., 46, 6387
- Hong R. L., 1999, Clin. Cancer Res., 5, 3645
- Torchilin V. P., 1985, Crit. Rev. Ther. Drug Carrier Syst., 2, 65
- Park J. W., 2002, Clin. Cancer Res., 8, 1172
- Andreev O. A., 2009, Chim. Oggi, 27, 34
- Ben-Yosef R., 2002, Harefuah, 141, 500
- Wood B., 2007, Gastrointestinal Cancers Symposium
- Needham D., 2000, Cancer Res., 60, 1197
- Peng T., 2014, Circulation, 130, A15737
- Naji A. K., 2014, Arterioscler., Thromb., Vasc. Biol., 34, A263
- Lee S. Y., 2014, Biomed. Mater. Eng., 24, 61
- Bressler N., 2001, JAMA Ophthalmol., 119, 198
- Ichihara H., 2008, Anticancer Res., 28, 1187
- Ichihara H., 2014, Anticancer Res., 34, 4701
- Kitamura I., 1996, Cancer Res., 56, 3986
- Tsujiuchi T., 2014, Am. J. Transl. Res., 6, 169
- Guo J., 2014, Biomed. Res. Int., 2014, 292471
- Gangishetty H., 2014, Pharm. Dev. Technol., 1
- Arrieta O., 2014, Cancer Chemother. Pharmacol., 1
- Chang H. I., 2012, Int. J. Nanomed., 7, 49
Cited by
Sorted by citations
Tenchov, R., Bird, R., Curtze, A. E., & Zhou, Q. (2021) · ACS Nano · doi:10.1021/acsnano.1c04996 · Cited by 2,221
Applications of nanoparticle systems in drug delivery technology
Rizvi, S. A. A., & Saleh, A. (2017) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2017.10.012 · Cited by 1,398
Liu, P., Chen, G., & Zhang, J. (2022) · Molecules · doi:10.3390/molecules27041372 · Cited by 1,334
Polymeric Nanoparticles for Drug Delivery
Beach, M. A., Nayanathara, U., Gao, Y., Zhang, C., Xiong, Y., Wang, Y., & Such, G. K. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00705 · Cited by 1,279
Design of liposomes as drug delivery system for therapeutic applications
Guimarães, D., Cavaco-Paulo, A. M., & Nogueira, E. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120571 · Cited by 1,266
Metadata
- Authors
- Pattni, B. S., Chupin, V. V., & Torchilin, V. P.
- Affiliations
- Northeastern University (US)
- Moscow Institute of Physics and Technology (RU)
- Corresponding author
- Torchilin, Vladimir P.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2015-05-26
- Volume
- 115
- Issue
- 19
- Pages
- 10938-10966
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W2300671107
- Cited by
- 1,600
- References
- 429
- Citations by year
- 2026: 95 · 2025: 132 · 2024: 141 · 2023: 142 · 2022: 155 · 2021: 191 · 2020: 195 · 2019: 170 · 2018: 150 · 2017: 135 · 2016: 83 · 2015: 11
- FWCI
- 7.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Chemical Reviews (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (5U54CA151881)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Keywords
- liposomal drug delivery, liposomes, liposome encapsulation, lipids, vesicle membrane composition, targeted drug delivery, tumor targeting, liposome biodistribution, liposome clearance, liposome toxicity, liposome surface modification
- MeSH terms
- Animals, Drug Carriers, Pharmaceutical Preparations, Humans, Liposomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
